Dr. Henry Chi Hang Fung to Oversee Bone Marrow Transplant Services at Fox Chase Cancer Center
PHILADELPHIA, PA (January 7, 2014)—Henry Chi Hang Fung, MD, FRCPE, a well-known leader in the field of blood diseases and bone marrow transplantation, has joined Fox Chase Cancer Center. At Fox Chase, Fung will serve as Clinical Leader of the Blood Cancers Program and the Hematologic Oncology Service Line, and Professor of Medical Oncology. He will also be Director of the Temple University Hospital Bone Marrow Transplant Program.
“Dr. Fung is internationally recognized for his clinical and scientific expertise in bone marrow transplantation, and his arrival is an important step in building a major hematologic malignancy program at Fox Chase Cancer Center,” says Richard I. Fisher, MD, President and CEO of Fox Chase Cancer Center and Senior Associate Dean of Temple University School of Medicine. “Being able to enhance our capabilities in this vital area of oncology is the latest example of how our affiliation with Temple University Health System continues to strengthen our overall capacities.”
Dr. Fung comes to Fox Chase from Rush University Medical Center, where he has been Professor of Medicine since 2005. While there he served as Director of the Section of Bone Marrow Transplant and Cell Therapy; Director of the Coleman Foundation Blood and Marrow Transplant Center, where he also held the Coleman endowed chair; Clinical Leader of Hematologic Malignancies; and Senior Attending Physician.
He received his MBChB (Bachelor of Medicine and Bachelor of Surgery degrees) from the Chinese University of Hong Kong and completed his internal medicine training through the Royal College of Physicians in the United Kingdom. Dr. Fung interned at the Prince of Wales Hospital, Chinese University of Hong Kong and undertook his residency at Queen Mary Hospital, Hong Kong University.
He completed his training as a hematology/BMT fellow at Vancouver Hospital and Health Science Center, British Columbia Cancer Control Agency, University of British Columbia. His first faculty appointment was as an Attending Physician and Clinical Investigator, Division of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center and Beckman Research Institute and City of Hope Comprehensive Cancer Center.
Dr. Fung has received many professional honors and awards, including the Excellence Award from the Chicago Chapter of the Lymphoma Research Foundation; an Innovation Award from the American College of Health Executives; and designation as one of the Leading Physicians of the World and the Top Oncologist in Chicago from the International Association of Oncologists.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.